2024-12-19 - Analysis Report
## ISRG (Intuitive Surgical Inc) Stock Analysis Report

**1. Relative Performance vs. S&P 500:**

Intuitive Surgical Inc. is a company that develops, manufactures, and markets robotic surgical systems. The cumulative return of ISRG is 300.04%, significantly outperforming the S&P 500 (VOO) which returned 120.85%.  This represents a difference of 179.19 percentage points.  The relative strength indicator (relative divergence) suggests ISRG is positioned in the 95.2 percentile of its historical performance range relative to the S&P 500.

Analyzing the provided alpha/beta table reveals consistently high alpha, suggesting significant outperformance compared to the market, coupled with a beta of 0, indicating little correlation with market movements.  CAGR is generally strong, although it has declined in recent years. MDD remains relatively consistent around 9-20%.  Market cap has steadily increased over the years.

**2. Recent Price Movement:**

* Closing Price: 545.16
* Last Market Price: 546.71
* 5-Day Moving Average: 543.01
* 20-Day Moving Average: 543.145
* 60-Day Moving Average: 516.6402

The stock price is currently slightly above both its 5-day and 20-day moving averages, suggesting a recent short-term upward trend.  The price is also significantly above the 60-day moving average, indicating a longer-term positive trend.

**3. RSI, PPO, and Expected Return:**

* RSI: 52.94
* PPO: -0.2996

The RSI indicates the stock is neither overbought nor oversold. The negative PPO suggests that the short-term moving average is below the longer-term moving average, hinting at potentially weakening momentum. The recent increase in relative strength (+2.4) over the past 20 days indicates short-term upward momentum against the S&P 500.  The expected return of 106.5% over the long term (2+ years) relative to the S&P 500 is very bullish.

**4. Recent Earnings Analysis:**

* Revenue has shown steady growth, increasing from $1.74B in Q3 2023 to $2.04B in Q3 2024.
* EPS has also generally increased, from $1.18 in Q3 2023 to $1.59 in Q3 2024. There was a slight dip in Q2 2024 ($1.48) compared to Q1 2024 ($1.54). 
* There is a duplicate entry for 2024-10-18 which might be an error.
* Without context regarding expectations, it's impossible to determine if these results represent beats or misses.

**5. Financial Information Analysis:**

* Revenue has steadily increased over the past five quarters.
* Profit margins remain consistently high, ranging from 65.87% to 68.30%.
* ROE has fluctuated between 3.32% and 4.56% over the past five quarters. While ROE is positive, it's relatively low, suggesting that the company may not be utilizing its equity as efficiently as it could be.  Equity has also consistently grown.

**6. News and Recent Issues:**

This section requires external information that is not provided in the prompt.  Key information to look for would include:

* Details surrounding the latest earnings release (2024-10-18).
* Analyst ratings changes and price targets.
* Any significant news related to the company's products, competition, or industry trends.
* Overall market sentiment and economic outlook.


**7. Summary:**

ISRG has demonstrated strong historical performance, significantly outperforming the S&P 500. Recent price trends are positive, although momentum indicators like PPO suggest some caution.  Earnings and revenue continue to grow, albeit at a slower pace recently, and profit margins remain strong.  ROE is relatively low but positive.  Further investigation into recent news and analyst opinions is crucial for a complete investment analysis. The high expected future return suggests strong long-term potential, but this should be validated with independent research.  The provided data suggests a generally positive outlook, but investors should consider potential risks and conduct thorough due diligence before making investment decisions.
